Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants82

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants46

Views

Views
February 20257
March 202514
April 20253
May 20251
June 20254
July 202516
August 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States23
Singapore14
Brazil4
United Kingdom2
Ecuador1
Spain1
Mexico1
 

Top cities views

Views
Brasília1
Buffalo1
Chicago1
Columbus1
Conyers1
Council Bluffs1
Erie1
Lancaster1
Mexico City1
Minneapolis1